FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200581640> ?p ?o ?g. }

• W4200581640 abstract "Intro: Deregulated protein synthesis is a common trait across solid and hematologic malignancies and an attractive target for cancer therapy. Rocaglates compounds that inhibit eukaryotic initiation factor 4A1 (eIF4A1), the essential DEAD-box RNA helicase that resolves mRNA 5’UTR secondary structures during cap-dependent translation initiation. Rocaglates’ unique mechanism of action causes sequence-selective mRNA binding by eIF4A1, clamping the inactive helicase onto the transcript. This suppresses translation globally and affects many oncogenic and pro-survival transcripts in particular. Zotatifin, the first-in class synthetic rocaglate, is currently in Phase I clinical trials for the treatment of solid tumors and as an antiviral against SARS-CoV2. Currently, eIF4A1 and DDX3 are the only reported targets of rocaglate-mediated RNA clamping. Employing unbiased proteomic approaches, we have discovered that rocaglates, thought to act as pure eIF4A/translation inhibitors, extensively remodel the translation machinery and translatome. Additionally, mass-spec interrogation for proteins interacting with specific RNA sequences reveals novel targets of rocaglate-mediated, sequence-specific RNA clamping. Methods: We conducted original mass-spectrometry analyses of translational reprogramming by rocaglates. TMT-pSILAC assessed acute changes in protein production, while MATRIX, which captures high-resolution profiles of the translation machinery, revealed translation factors that drive reprogramming in response to rocaglate exposure. We validated results biochemically, in cellulo, and in vivo using patient-derived xenograft (PDX) mouse models. To probe existing and novel rocaglate RNA-clamping targets, we developed unbiased “clampome” assays – in cellulo protein-RNA-pull downs followed by mass-spec analysis of proteins with increased binding to RNA in the presence of rocaglates. Results: We find rocaglates, including zotatifin, have effects far more complex than simple “translational inhibition” as currently defined. Indeed, translatome analysis by TMT-pSILAC revealed myriad up-regulated proteins that drive hitherto unrecognized cytotoxic mechanisms. The GEF-H1 guanine exchange factor, for example, drives anti-survival RHOA/JNK activation, suggesting novel candidate biomarkers of rocaglate clinical outcomes. Translation-machinery analysis by MATRIX identifed rocaglate-induced dependence on specific translation factors including eEF1ε1 that drive remodeling. Novel rocaglate RNA-binding targets revealed by clampome studies remain under detailed evaluation as mediators of drug activities. Discussion: Our original proteome-level interrogation revealed that the complete cellular response to these historical “translation inhibitors” is mediated by comprehensive translational landscape remodeling. Effects on a broader suite of RNA binding proteins than eIF4A1 alone we suggest mediate the potent antitumor activities of these unique compounds, elucidation of which permits development of novel precision approaches to targeted translational deregulation in cancer. <b>Citation Format:</b> Tyler A. Cunningham, J. J. David Ho, Paola Manara, Stephen Lee, Jonathan H. Schatz. Proteomic approaches define rocaglates as translation remodelers with multiple protein targets [abstract]. In: Proceedings of the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics; 2021 Oct 7-10. Philadelphia (PA): AACR; Mol Cancer Ther 2021;20(12 Suppl):Abstract nr P028." @default.
• W4200581640 created "2021-12-31" @default.
• W4200581640 creator A5012500790 @default.
• W4200581640 creator A5025312170 @default.
• W4200581640 creator A5031050440 @default.
• W4200581640 creator A5035535768 @default.
• W4200581640 creator A5063901652 @default.
• W4200581640 date "2021-12-01" @default.
• W4200581640 modified "2023-10-16" @default.
• W4200581640 title "Abstract P028: Proteomic approaches define rocaglates as translation remodelers with multiple protein targets" @default.
• W4200581640 doi "https://doi.org/10.1158/1535-7163.targ-21-p028" @default.
• W4200581640 hasPublicationYear "2021" @default.
• W4200581640 type Work @default.
• W4200581640 citedByCount "0" @default.
• W4200581640 crossrefType "proceedings-article" @default.
• W4200581640 hasAuthorship W4200581640A5012500790 @default.
• W4200581640 hasAuthorship W4200581640A5025312170 @default.
• W4200581640 hasAuthorship W4200581640A5031050440 @default.
• W4200581640 hasAuthorship W4200581640A5035535768 @default.
• W4200581640 hasAuthorship W4200581640A5063901652 @default.
• W4200581640 hasConcept C104317684 @default.
• W4200581640 hasConcept C105580179 @default.
• W4200581640 hasConcept C142587794 @default.
• W4200581640 hasConcept C149364088 @default.
• W4200581640 hasConcept C161223559 @default.
• W4200581640 hasConcept C3675279 @default.
• W4200581640 hasConcept C4718897 @default.
• W4200581640 hasConcept C54355233 @default.
• W4200581640 hasConcept C62493599 @default.
• W4200581640 hasConcept C67705224 @default.
• W4200581640 hasConcept C68592252 @default.
• W4200581640 hasConcept C70721500 @default.
• W4200581640 hasConcept C77255625 @default.
• W4200581640 hasConcept C77430603 @default.
• W4200581640 hasConcept C86803240 @default.
• W4200581640 hasConcept C89604277 @default.
• W4200581640 hasConcept C95444343 @default.
• W4200581640 hasConcept C99348085 @default.
• W4200581640 hasConceptScore W4200581640C104317684 @default.
• W4200581640 hasConceptScore W4200581640C105580179 @default.
• W4200581640 hasConceptScore W4200581640C142587794 @default.
• W4200581640 hasConceptScore W4200581640C149364088 @default.
• W4200581640 hasConceptScore W4200581640C161223559 @default.
• W4200581640 hasConceptScore W4200581640C3675279 @default.
• W4200581640 hasConceptScore W4200581640C4718897 @default.
• W4200581640 hasConceptScore W4200581640C54355233 @default.
• W4200581640 hasConceptScore W4200581640C62493599 @default.
• W4200581640 hasConceptScore W4200581640C67705224 @default.
• W4200581640 hasConceptScore W4200581640C68592252 @default.
• W4200581640 hasConceptScore W4200581640C70721500 @default.
• W4200581640 hasConceptScore W4200581640C77255625 @default.
• W4200581640 hasConceptScore W4200581640C77430603 @default.
• W4200581640 hasConceptScore W4200581640C86803240 @default.
• W4200581640 hasConceptScore W4200581640C89604277 @default.
• W4200581640 hasConceptScore W4200581640C95444343 @default.
• W4200581640 hasConceptScore W4200581640C99348085 @default.
• W4200581640 hasLocation W42005816401 @default.
• W4200581640 hasOpenAccess W4200581640 @default.
• W4200581640 hasPrimaryLocation W42005816401 @default.
• W4200581640 hasRelatedWork W12786353 @default.
• W4200581640 hasRelatedWork W1452121 @default.
• W4200581640 hasRelatedWork W1890426 @default.
• W4200581640 hasRelatedWork W4613470 @default.
• W4200581640 hasRelatedWork W5794924 @default.
• W4200581640 hasRelatedWork W6076774 @default.
• W4200581640 hasRelatedWork W6801888 @default.
• W4200581640 hasRelatedWork W8197396 @default.
• W4200581640 hasRelatedWork W8523760 @default.
• W4200581640 hasRelatedWork W8995065 @default.
• W4200581640 isParatext "false" @default.
• W4200581640 isRetracted "false" @default.
• W4200581640 workType "article" @default.